We believe interactions with health care professionals bring value to patient care. Our interactions with them are guided by openness and transparency. This is especially important when it comes to financial payments or other forms of value provided. Demonstrating the integrity of our relationships with health care professionals through transparency and disclosure is an important part of these relationships.
The Sunshine Act became federal law in 2010. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers and health care organizations and to disclose those transactions on an annual basis. As part of AbbVie's Corporate Integrity Agreement, AbbVie's U.S. business has agreed to post payments to physicians that would be reported annually under the Sunshine Act on a quarterly basis. We support the Sunshine Act and its goal of providing the public greater visibility into interactions between the health care industry and health care professionals to ensure public trust and confidence.
The report is based on transactional data that has been aggregated at a particular point in time; some payments and transfers of value that take place during the reporting period may be included in the next quarter's report. Posted data may not correlate to state transparency reports due to differences in the scope and requirements between the various transparency laws. Changes or additions that are identified after the report is posted will be accounted for in the next quarter's report. Due to the requirements for reporting related entities/payees, some payments shown on the report are included more than once.
The types of payments and transfers of value included in the report are as follows:
Business Meals, which include reimbursed amounts for meals incurred in the course of providing contracted-for services such as consulting and research; and meals provided in connection with an educational or business discussion
Business Travel, which includes reimbursed amounts and the value of directly-provided transportation (e.g., airfare, taxi service) incurred in the course of providing contracted-for services, such as consulting and research
Educational Materials and Items, which includes reference material such as journal articles, textbooks, and anatomical models
Professional Services, which include payments for contracted-for services, such as speaking at an educational seminar or serving on a data safety monitoring board
Research Related Payments, which include payments for research and clinical trial activities, royalties, and license fees
For individuals with a year-to-date total of $100 or less, individual payments and transfers of value less than $10 are excluded from the report, as provided for by the Sunshine Act.
1st, 2nd, 3rd and 4th Quarter 2013 Physician Payment Report
Q3 and Q4 2013 Supplemental Report - Indirect Research Payments Made To Entities
2012 Annual Physician Payment Report (July 1 - December 31)
2013 Annual Physician Payment Report
2013 Annual Supplemental Report – Indirect Research Payments Made to Entities (August 1 – December 31)
If you have questions on the data contained in the reports, please email TransparencyReporting@abbvie.com.